Zhongji InnoLight Co., Ltd. Announces Final Offer Price and Allotment Results for HKEX Listing
Key Highlights and Investor Takeaways
- Listing Details: Zhongji InnoLight Co., Ltd. (“the Company”) has announced the final offer price and allotment results for its global offering of H Shares on the Hong Kong Stock Exchange (HKEX), with trading set to commence on July 30, 2026 under stock code 3308. The stock short name will be ZJ INNOLIGHT.
- Final Offer Price: The final offer price for the H Shares is set at HK\$980.00 per share, marginally below the maximum offer price of HK\$1,010.00.
- Size of Offering: A total of 54,500,000 H Shares were offered, comprising 5,450,000 shares in the Hong Kong Public Offering (10%) and 49,050,000 shares in the International Offering (90%). There was an over-allocation of 8,175,000 shares, which may be covered by an over-allotment option or secondary market purchases.
- Proceeds: The gross proceeds from the offering are approximately HK\$53,410 million, with estimated listing expenses of HK\$519 million, resulting in net proceeds of HK\$52,891 million.
- Warning on Shareholding Concentration: The Company issued a caution regarding the high concentration of shareholdings in a small number of shareholders, warning that the share price could be highly volatile even on low trading volume. Investors are advised to exercise extreme caution.
Allotment Results in Detail
Hong Kong Public Offering
- Subscription: The Hong Kong Public Offering was oversubscribed by 16.84 times, with 62,731 valid applications and 51,199 successful applicants.
- Claw-back: No claw-back was triggered, and the final allocation remained at 5,450,000 H Shares.
International Offering
- Subscription: The International Offering was 9.73 times oversubscribed, with 549 placees.
- Allocation: All 49,050,000 H Shares were allocated, representing 90% of the total offering.
Cornerstone Investors and Lock-Up
- Cornerstone Investors: 27,249,400 H Shares (50% of the International Offering and 2.33% of the total issued share capital after listing) were allocated to cornerstone investors, including major names like Taibai, BlackRock, JPMorgan, Wellington, Alibaba, Tencent, CPP Investments, Bain Capital, and others.
- Lock-up Arrangements: All cornerstone investors are subject to a six-month lock-up period, expiring January 29, 2027. During this time, these shares cannot be sold or transferred.
Shareholder and Placee Concentration
- The top 1, 5, 10, and 25 placees in the International Offering were allotted 5.79%, 26.99%, 42.66%, and 68.20% of the International Offering, respectively—highlighting a significant concentration of H Shares among a small number of investors.
- For H Shareholders, the top 1, 5, 10, and 25 held 5.21%, 24.29%, 38.39%, and 61.38% of H shares, respectively.
- For all Shareholders (including A and H shares), the top 1, 5, 10, and 25 held 10.38%, 27.87%, 31.94%, and 37.67% of the total share capital, respectively.
Regulatory Waivers, Consents, and Connected Clients
- The Company obtained waivers and consents from the HKEX to allocate shares to certain existing minority shareholders and connected clients, all in accordance with the Listing Rules and Placing Guidelines.
- Detailed breakdowns of allocations are provided for all connected clients and collective investment schemes, none of which are expected to impact public float or breach regulations.
Public Float and Free Float
- The Company expects a market value of H Shares held by the public of approximately HK\$53.4 billion, well above the HKEX requirement of HK\$3.0 billion.
- At least 300 shareholders will hold the H Shares, with no individual placee allotted more than 10% of the enlarged share capital, and no new substantial shareholder will be created by the Global Offering.
- Free float requirement is met, but shares held by cornerstone investors are not counted toward free float during their lock-up.
Potential Price-Sensitive Developments
- Potential A Share Repurchase: The Company is considering a potential A Share repurchase plan, as proposed by Dr. Liu Sheng (Chairman and President). This proposal is still subject to board approval, and no repurchase has yet occurred. The source of funds will not include proceeds from the H Share Offering. If implemented, this could signal management’s confidence and be price supportive for A and H shares.
- High Shareholding Concentration Risk: High concentration could result in significant price volatility, triggering both upside or downside moves on limited trading activity.
Other Important Information for Investors
- Trading: H Shares will be traded in board lots of 50 shares each, with the stock code 3308. Trading is expected to commence at 9:00 a.m. on July 30, 2026.
- Compliance: The Company confirms full compliance with the Listing Rules, with all necessary waivers and consents disclosed.
- Termination Rights: The underwriting agreement allows for termination by underwriters on specific grounds prior to 8:00 a.m. on the Listing Date.
Conclusion
The listing of Zhongji InnoLight on the HKEX is a significant capital markets event, with strong demand from both public and institutional investors, including many global cornerstone investors. The high shareholding concentration and pending A Share buyback proposal are the most price-sensitive points. Investors should remain aware of the potential for share price volatility due to the concentrated ownership structure and monitor any announcements relating to the A Share repurchase plan.
Disclaimer
This article is for information purposes only and is not investment advice. Potential investors should read the Company’s Prospectus and seek professional advice before acting. The author accepts no liability for investment decisions made based on this article.
中際旭創股份有限公司發佈H股招股定價及配股結果詳情
重點摘要及投資者須知
- 上市詳情：中際旭創股份有限公司（「公司」）已公佈其H股全球發售的最終定價及配股結果，預計於2026年7月30日於香港聯交所（股份代號 3308）掛牌上市，股票簡稱為ZJ INNOLIGHT。
- 最終發售價：H股最終定價為每股港幣980.00元，略低於最高發售價港幣1,010.00元。
- 發售規模：合共54,500,000股H股，當中包括5,450,000股香港公開發售（10%）及49,050,000股國際配售（90%）。其中有8,175,000股被超額配售，可透過超額配股權或二級市場購買覆蓋。
- 集資：總集資額約港幣534.1億元，扣除上市開支港幣5.19億元，淨集資約港幣528.91億元。
- 持股集中度風險：公司特別提醒，股份高度集中於少數股東，意味著即使成交量不大，股價亦可能出現大幅波動，投資者應格外審慎。
配股詳情
香港公開發售
- 認購情況：香港公開發售超額認購16.84倍，共收到62,731份有效申請，51,199人成功獲配。
- 回撥：未觸發回撥，最終配發5,450,000股H股。
國際配售
- 認購情況：國際配售亦超額認購9.73倍，合共549位配售對象。
- 配發：全部49,050,000股H股獲派，占總發售90%。
基石投資者及禁售安排
- 基石投資者：共有27,249,400股H股（國際配售50%，上市後總已發行股份2.33%）分配予基石投資者，包括太白、黑石、摩根大通、惠理、阿里巴巴、騰訊、加拿大養老基金、貝恩資本等多家機構。
- 禁售期：基石投資者須持有六個月（至2027年1月29日）。禁售期內不得出售或轉讓。
股東及配售集中度
- 國際配售中，首1、5、10及25名配售人分別獲配5.79%、26.99%、42.66%及68.20%的H股，反映股份高度集中。
- H股股東方面，前1、5、10及25名持有5.21%、24.29%、38.39%及61.38%的H股。
- 計及A+H股，前1、5、10及25名股東持有10.38%、27.87%、31.94%及37.67%的公司總股份。
監管豁免、同系分配及關連人配售
- 公司已取得聯交所豁免及同意，合規分配予部分現有少數股東及關連人，並詳列所有配股、基金及投資產品分配，確保不影響公眾持股量及不違反規例。
公眾持股及自由流通量
- 公眾持有H股市值預計約港幣534億元，遠超港交所規定的30億元。
- 至少有300名股東持有H股，無單一配售人獲配超過擴大後股份10%，亦不會產生新主要股東，自由流通量合規。
- 基石投資者持股禁售期內不計入自由流通量。
潛在影響股價的敏感事項
- 潛在A股回購計劃：公司正考慮進行A股回購（董事長劉聖博士提議，但尚待董事會審批），目前尚未實施，資金來源不包括H股集資。若落實，反映管理層對公司前景有信心，或有助支持股價。
- 高度持股集中風險：股份集中於少數股東，或導致低成交下價格大幅波動，短線投資者需留意。
其他投資者重要資訊
- 買賣安排：H股以每手50股買賣，股份代號3308，預計7月30日（星期四）上午9時正開始交易。
- 合規聲明：公司確認已完全遵守上市規則，所有豁免及同意已公開披露。
- 承銷協議：如於上市日前發生特定事件，承銷商有權終止協議。
總結
中際旭創H股上市廣受追捧，基石及機構投資者反應熱烈。需特別關注持股集中及A股潛在回購計劃這兩大對股價有明顯影響的事項。建議投資者密切留意公司後續公告及市場動態。
免責聲明
本文僅供資訊參考，並非投資建議。請仔細閱讀公司招股書並諮詢專業顧問後才作投資決定。作者對任何因本文而作出的投資決定不承擔任何責任。
